Arise AB (publ) (FRA:A4W)

Blueprint Medicines Statistics

Total Valuation

Arise AB has a market cap or net worth of EUR 124.64 million. The enterprise value is 209.98 million.

Market Cap	124.64M
Enterprise Value	209.98M

Important Dates

The last earnings date was Friday, July 18, 2025.

Earnings Date	Jul 18, 2025
Ex-Dividend Date	May 8, 2025

Share Statistics

Current Share Class	40.79M
Shares Outstanding	n/a
Shares Change (YoY)	-3.49%
Shares Change (QoQ)	-0.77%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	21.98M

Valuation Ratios

The trailing PE ratio is 15.64 and the forward PE ratio is 4.95.

PE Ratio	15.64
Forward PE	4.95
PS Ratio	2.75
PB Ratio	0.66
P/TBV Ratio	0.79
P/FCF Ratio	39.77
P/OCF Ratio	5.73
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.77, with an EV/FCF ratio of 67.00.

EV / Earnings	26.35
EV / Sales	4.64
EV / EBITDA	12.77
EV / EBIT	24.23
EV / FCF	67.00

Financial Position

The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.34.

Current Ratio	1.17
Quick Ratio	0.22
Debt / Equity	0.34
Debt / EBITDA	3.93
Debt / FCF	20.69
Interest Coverage	1.76

Financial Efficiency

Return on equity (ROE) is 4.94% and return on invested capital (ROIC) is 1.95%.

Return on Equity (ROE)	4.94%
Return on Assets (ROA)	1.73%
Return on Invested Capital (ROIC)	1.95%
Return on Capital Employed (ROCE)	3.41%
Revenue Per Employee	596,170
Profits Per Employee	104,860
Employee Count	73
Asset Turnover	0.14
Inventory Turnover	n/a

Taxes

Income Tax	-3.31M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.54% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-31.54%
50-Day Moving Average	3.11
200-Day Moving Average	3.22
Relative Strength Index (RSI)	46.14
Average Volume (20 Days)	778

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Arise AB had revenue of EUR 45.31 million and earned 7.97 million in profits. Earnings per share was 0.19.

Revenue	45.31M
Gross Profit	42.89M
Operating Income	8.69M
Pretax Income	6.09M
Net Income	7.97M
EBITDA	15.85M
EBIT	8.69M
Earnings Per Share (EPS)	0.19

Balance Sheet

The company has 8.06 million in cash and 64.83 million in debt, giving a net cash position of -56.77 million.

Cash & Cash Equivalents	8.06M
Total Debt	64.83M
Net Cash	-56.77M
Net Cash Per Share	n/a
Equity (Book Value)	189.12M
Book Value Per Share	3.93
Working Capital	6.36M

Cash Flow

In the last 12 months, operating cash flow was 21.76 million and capital expenditures -18.62 million, giving a free cash flow of 3.13 million.

Operating Cash Flow	21.76M
Capital Expenditures	-18.62M
Free Cash Flow	3.13M
FCF Per Share	n/a

Margins

Gross margin is 94.66%, with operating and profit margins of 19.17% and 17.59%.

Gross Margin	94.66%
Operating Margin	19.17%
Pretax Margin	13.44%
Profit Margin	17.59%
EBITDA Margin	34.98%
EBIT Margin	19.17%
FCF Margin	6.92%

Dividends & Yields

This stock pays an annual dividend of 0.11, which amounts to a dividend yield of 3.76%.

Dividend Per Share	0.11
Dividend Yield	3.76%
Dividend Growth (YoY)	11.37%
Years of Dividend Growth	2
Payout Ratio	57.30%
Buyback Yield	3.49%
Shareholder Yield	7.25%
Earnings Yield	6.39%
FCF Yield	2.51%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5